A study conducted by the American Chemical Society and the American Society of Pharmacognosy, and published by the Journal of Natural Products, has found that cannabis can combat deadly, treatment resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), a fatal bacteria that kills thousands yearly.
According to the study, all five of the major cannabinoids found in cannabis (cannabidiol , cannabichromene, cannabigerol, delta-9-tetrahydrocannabinol and cannabinol) showed “potent antibacterial activity”, and was found to combat a variety of dangerous bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), as well as the “recently emerged and extremely drug-resistant Mycobacterium tuberculosis”.
Researchers conclude that; “This plant represents an interesting source of antibacterial agents to address the problem of multidrug resistance in MRSA and other pathogenic bacteria. This issue has enormous clinical implications, since MRSA is spreading throughout the world and, in the United States, currently accounts for more deaths each year than AIDS”.
The study is one of the most comprehensive of its kind to show that cannabis has the potential to combat deadly, antibiotic-resistant bacteria.